Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (261-270 of 333) with videos related to

Pageof 34
Sort By:
JAMA|January 30, 2004
Effect of breast augmentation on the accuracy of mammography and cancer characteristicsDiana L Miglioretti, Carolyn M Rutter, Berta M Geller, et al.
The Lancet. Neurology|November 23, 2020
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialBruce A C Cree, Gary Cutter, Jerry S Wolinsky, et al.
The New England Journal of Medicine|September 30, 2016
Adjunctive Azithromycin Prophylaxis for Cesarean DeliveryAlan T N Tita, Jeff M Szychowski, Kim Boggess, et al.
Muscle & Nerve|May 7, 2021
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE)Amanda C Guidon, Srikanth Muppidi, Richard J Nowak, et al.
The Lancet. Neurology|April 28, 2022
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trialJohn F Foley, Gilles Defer, Lana Zhovtis Ryerson, et al.
Journal of the National Cancer Institute|October 17, 2002
Detection of ductal carcinoma in situ in women undergoing screening mammographyVirginia L Ernster, Rachel Ballard-Barbash, William E Barlow, et al.
The American Journal of the Medical Sciences|July 6, 2022
Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trialMaria I Danila, Dongmei Sun, Lesley E Jackson, et al.
Neurology|September 14, 2019
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosingLana Zhovtis Ryerson, John Foley, Ih Chang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 25, 2020
Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's DiseaseAmy W Amara, Kimberly H Wood, Allen Joop, et al.
The Lancet. Neurology|July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trialNir Giladi, Roy N Alcalay, Gary Cutter, et al.
Pageof 34

Showing results (261-270 of 333) with videos related to

Sort By:
Pageof 34
JAMA|January 30, 2004
Effect of breast augmentation on the accuracy of mammography and cancer characteristicsDiana L Miglioretti, Carolyn M Rutter, Berta M Geller, et al.
The Lancet. Neurology|November 23, 2020
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialBruce A C Cree, Gary Cutter, Jerry S Wolinsky, et al.
The New England Journal of Medicine|September 30, 2016
Adjunctive Azithromycin Prophylaxis for Cesarean DeliveryAlan T N Tita, Jeff M Szychowski, Kim Boggess, et al.
Muscle & Nerve|May 7, 2021
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE)Amanda C Guidon, Srikanth Muppidi, Richard J Nowak, et al.
The Lancet. Neurology|April 28, 2022
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trialJohn F Foley, Gilles Defer, Lana Zhovtis Ryerson, et al.
Journal of the National Cancer Institute|October 17, 2002
Detection of ductal carcinoma in situ in women undergoing screening mammographyVirginia L Ernster, Rachel Ballard-Barbash, William E Barlow, et al.
The American Journal of the Medical Sciences|July 6, 2022
Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trialMaria I Danila, Dongmei Sun, Lesley E Jackson, et al.
Neurology|September 14, 2019
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosingLana Zhovtis Ryerson, John Foley, Ih Chang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 25, 2020
Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's DiseaseAmy W Amara, Kimberly H Wood, Allen Joop, et al.
The Lancet. Neurology|July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trialNir Giladi, Roy N Alcalay, Gary Cutter, et al.
Pageof 34